ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Celgene’s luspatercept aces phase 3 beta thalassemia trial fiercebiotech
January 03, 2019A phase 3 trial of Celgene’s luspatercept in adults with beta thalassemia has hit its primary goal. The late-phase success tees Celgene to file for approval of its Acceleron-partnered blockbuster prospect in the first half of next year......
Pharma Sources Insight January 2025
